A 52-year-old with T2D and A1c 7.2% on metformin has prior MI and normal EF. Which additional therapy offers CV risk reduction independent of A1c?...

Question

A 52-year-old with T2D and A1c 7.2% on metformin has prior MI and normal EF. Which additional therapy offers CV risk reduction independent of A1c?

Accepted Answer

SGLT2 inhibitor with CV benefit

Answer

Sulfonylurea

Answer

Alpha-glucosidase inhibitor

Answer

Basal insulin

Answer

DPP‑4 inhibitor

us-abim MCQ (SBA): Type 2 Diabetes-Cardiovascular Risk